Fundraising Fox
Temprian Therapeutics
Chicago, US · Founded 2019 · Delaware corporation · 3 employees on LinkedIn · 1 known investors
Find your way into Temprian Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Markwin Velders to introduce you to John Nieland
You →Markwin · together at Loyola University Medical Center →John
Ask Jamie Chen to introduce you to Paul Burton
You →Jamie · together at Vivacelle Bio →Paul
Sign up to find every way you can get introduced to Temprian Therapeutics
- Your email: who you already know at Temprian Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Temprian Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo. It focuses on advancing a treatment for pigmentation disorders through clinical development.
Founders & leadership
Temprian Therapeutics was founded in 2019 by Isabelle Caroline Le Poole and Caroline Le Poole.
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$275K disclosed across 1 round · 2019
▶$275KraisedNov 2019 · 1 investors · PharmaceuticalsRule 506(b)
- Kettil CedercreutzExecutive Officer, Director
- Isabelle Caroline Le PooleExecutive Officer, Director
- Offering amount
- $325K
- Amount sold
- $275K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Temprian Therapeutics do?
- Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo. It focuses on advancing a treatment for pigmentation disorders through clinical development.
- Who founded Temprian Therapeutics?
- Temprian Therapeutics was founded by Isabelle Caroline Le Poole, Caroline Le Poole in 2019.
- Who are Temprian Therapeutics's investors?
- Temprian Therapeutics's investors include 2Flo Ventures.
- How much funding has Temprian Therapeutics raised?
- Temprian Therapeutics has disclosed $275K raised across 1 round.
- Where is Temprian Therapeutics headquartered?
- Temprian Therapeutics is headquartered in Chicago, US.